Articles 2026
Hosseiniyan N, Castronovo P, Beaune G, Abdelrady E, Chen X, Zhyvolozhnyi A, Siddiqui H, Farhana J, Jiang H, Makki M, Cannas M, Sciortino A, Skovorodkin I, Samoylenko A, Vainio SJ, Messina F, Chandra S. Synergistic Effects in Matrix-Embedded Alloy Nanoclusters: Advanced Type-I Photosensitizers for Theranostics. ACS Appl Mater Interfaces. 2026 Feb 11;18(5):8685-8698. doi: 10.1021/acsami.5c22942. Epub 2026 Jan 27. PMID: 41593870.
Consortium publications
The FinnGen Project
Brenna E, Ferro M, Sumelahti ML, Cajuso T, Ganna A, Rossi J, Tikkanen E; FinnGen Project. Clinical and genetic characterization of non-optimal triptan response among migraine patients. Cephalalgia. 2026 Jan;46(1):3331024251414621. doi: 10.1177/03331024251414621. Epub 2026 Jan 28. PMID: 41603368.
Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Burns A, Rasmussen M, Andersson NW, Quinn L; DBDS Genomic Consortium; Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H; Estonian Biobank Research Team; FinnGen; Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B. Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants. Nat Genet. 2026 Jan 22. doi: 10.1038/s41588-025-02484-9. Epub ahead of print. PMID: 41571831.
Hautakangas H, Kartau J; FinnGen; Palotie A, Pirinen M; International Headache Genetics Consortium. Fine-mapping a genome-wide meta-analysis of 98,374 migraine cases identifies 181 sets of candidate causal variants. Nat Commun. 2026 Jan 12;17(1):355. doi: 10.1038/s41467-025-64880-3. PMID: 41526330.
Heikkilä A, Sliz E, Väyrynen S, Reis K, Elnahas AG, Reigo A, Esko T; FinnGen; Estonian Biobank Research Team; Kettunen J, Hautala T. Genetic risk factors for pneumonia differ by patient subgroup. EBioMedicine. 2026 Jan 23;124:106136. doi: 10.1016/j.ebiom.2026.106136. Epub ahead of print. PMID: 41579494.
Jeskanen H, Heikkinen S, Kervinen I, Lehtisalo J, Ngandu T, Willman RM, Rosa J, Hoffmann D, Leinonen V, Haapasalo A, Takalo M, Martiskainen H, Hiltunen M; FinnGen. Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers. Alzheimers Res Ther. 2026 Jan 31. doi: 10.1186/s13195-026-01957-1. Epub ahead of print. PMID: 41620758.
Kirchler M, Ferro M, Lorenzini V, van de Water RP; FinnGen; Lippert C, Ganna A. Large language models improve transferability of electronic health record-based predictions across countries and coding systems. NPJ Digit Med. 2026 Jan 22. doi: 10.1038/s41746-026-02363-5. Epub ahead of print. PMID: 41571946.
Koivumäki M, Martiskainen H, Takalo M, Lehtisalo J, Ngandu T; FinnGen; Snellman A, Hiltunen M, Rinne JO. Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals. Alzheimers Res Ther. 2026 Feb 19. doi: 10.1186/s13195-026-01984-y. Epub ahead of print. PMID: 41709289.
Strom NI, Verhulst B, Bacanu SA, Cheesman R, Purves KL, Gedik H, Mitchell BL, Kwong AS, Faucon AB, Singh K, Medland S, Colodro-Conde L, Krebs K, Hoffmann P, Herms S, Gehlen J, Ripke S, Awasthi S, Palviainen T, Tasanko EM, Peterson RE, Adkins DE, Shabalin AA, Adams MJ, Iveson MH, Campbell A, Thomas LF, Winsvold BS, Drange OK, Børte S, Ter Kuile AR, Naamanka J, Nguyen TH, Meier SM, Corfield EC, Hannigan L, Levey DF, Czamara D, Weber H, Choi KW, Pistis G, Couvy-Duchesne B, Van der Auwera S, Teumer A, Karlsson R, Garcia-Argibay M, Lee D, Wang R, Bjerkeset O, Stordal E, Bäckman J, Salum GA, Zai CC, Kennedy JL, Zai G, Tiwari AK, Heilmann-Heimbach S, Schmidt B, Kaprio J, Kennedy MM, Boden J, Havdahl A, Middeldorp CM, Lopes FL, Akula N, McMahon FJ, Binder EB, Fehm L, Ströhle A, Castelao E, Tiemeier H, Stein DJ, Whiteman D, Olsen C, Fuller Z, Wang X, Wray NR, Byrne EM, Lewis G, Timpson NJ, Davis LK, Hickie IB, Gillespie NA, Milani L, Schumacher J, Woldbye DP, Forstner AJ, Nöthen MM, Hovatta I, Horwood J, Copeland WE, Maes HH, McIntosh AM, Andreassen OA, Zwart JA, Mors O, Børglum AD, Mortensen PB, Ask H, Reichborn-Kjennerud T, Najman JM, Stein MB, Gelernter J, Milaneschi Y, Penninx BW, Boomsma DI, Maron E, Erhardt-Lehmann A, Rück C, Kircher TT, Melzig CA, Alpers GW, Arolt V, Domschke K, Smoller JW, Preisig M, Martin NG, Lupton MK, Luik AI, Reif A, Grabe HJ, Larsson H, Magnusson PK, Oldehinkel AJ, Hartman CA, Breen G, Docherty AR, Coon H, Conrad R, Lehto K; Veterans Affairs Million Veteran Program; FinnGen; 23andMe Research Team; Deckert J, Eley TC, Mattheisen M, Hettema JM. Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling. Nat Genet. 2026 Feb;58(2):275-288. doi: 10.1038/s41588-025-02485-8. Epub 2026 Feb 3. PMID: 41634414.
Williams DM, Heikkinen S, Hiltunen M; FinnGen; Davies NM, Anderson EL. The proportion of Alzheimer’s disease attributable to apolipoprotein E. NPJ Dement. 2026;2(1):1. doi: 10.1038/s44400-025-00045-9. Epub 2026 Jan 9. PMID: 41522467.